Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 12/31/2019 (updated monthly) $1,203.8 (M)
Net Assets - Advisor ClassAs of 12/31/2019 (updated monthly) $164.6 (M)

Positions As of 12/31/2019

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 12/31/2019 (updated monthly) $29,297.59(M) $35,548.22(M)
P/B RatioAs of 12/31/2019 (updated monthly) 6.17 5.17
P/E Ratio (12-mo Forward)As of 12/31/2019 (updated monthly) 17.07 15.28
Price to Cash FlowAs of 12/31/2019 (updated monthly) 17.67 15.82

Portfolio Details

Asset AllocationAs of 12/31/2019

[name] [value]
Equity 96.19%
Cash & Cash Equivalents 3.81%

Geographic BreakdownAs of 12/31/2019

No chart available for this data.
[name] [value]
United States 82.68%
Cash & Cash Equivalents 3.81%
Netherlands 3.71%
United Kingdom 3.34%
Denmark 2.98%
Canada 1.83%
Switzerland 0.84%
Germany 0.82%

sector breakdownAs of 12/31/2019

[name] [value]
Biotechnology 79.06%
Pharmaceuticals 12.28%
Life Sciences Tools & Services 4.85%
Cash & Cash Equivalents 3.81%

TOP TEN HOLDINGSAs of 12/31/2019

Issuer Country Industry % of total
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 7.04%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.58%
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.62%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.85%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.67%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.03%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.83%
DECIPHERA PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.46%
GW PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 3.34%
HERON THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.14%

Market Capitalization BreakdownAs of 12/31/2019

[name] [value]
<2.0 Billion 20.58%
2.0-5.0 Billion 24.30%
5.0-10.0 Billion 15.66%
10.0-25.0 Billion 5.01%
25.0-50.0 Billion 9.23%
>50.0 Billion 24.85%
N/A 0.36%